
CHAMPS Sierra Leone
About Our Work
In Sierra Leone, CHAMPS is dedicated to improving child health outcomes through mortality surveillance in two critical districts: Bombali in the northern province and Bo in the southern province. Our catchment areas encompass Bombali Siari and Bombali Sebora chiefdoms, including parts of Makeni city, as well as Kakua, Tikonko chiefdoms, and Bo city in Bo district. The Bombali district was notably impacted during the 2014 Ebola outbreak, highlighting the importance of our efforts.
CHAMPS operates through a collaborative consortium of health organizations under the guidance of Sierra Leone’s Ministry of Health (MoH). World Hope International (WHI) leads our surveillance activities, which include monitoring mortality, pregnancy, and health demographics. FOCUS1000 focuses on community engagement and qualitative research. Utilizing existing community and MoH surveillance structures, we identify and report stillbirths and under-five deaths, ensuring accurate data collection.
The recently commissioned modern laboratory in Makeni Regional Hospital has enhanced clinical services and diagnostics. This includes microbiological and molecular testing. This state-of-the-art facility serves both CHAMPS research and MoH clinical diagnostics, contributing to post-Ebola health system strengthening. Histopathological testing is conducted at the Connaught Hospital Histopathology Laboratory in Freetown, the capital city.
Funding for the Makeni Regional Hospital was secured through a public-private partnership involving CDC Sierra Leone, the CDC Foundation, and the Bill & Melinda Gates Foundation. This partnership ensures a positive and sustainable impact on the health landscape in Sierra Leone. Through our data interventions and collaborative efforts, CHAMPS aims to foster a hopeful future for vulnerable children and communities across Sierra Leone.
Our Impact
In Sierra Leone, CHAMPS is making a significant impact on child health by conducting comprehensive mortality surveillance in two key districts. Through data interventions, local partnerships, and state-of-the-art facilities, we are addressing critical health challenges and creating a hopeful future for vulnerable communities.
0
Population Under Surveillance
0 /1000
Under-5 Mortality Rate
0 /1000
Infant Mortality Rate(/1000)
0 /1000
Neonatal Mortality Rate (/1000)
0 / 100,000
Maternal Mortality Rate
Data updated: 2021
FILTER BY:

Meet our Directors
Dr. Ike Ogbuanu is a medical doctor and epidemiologist with more than 20 years of progressive experience in clinical medicine, academic research, global public health, vaccinology, leadership and management. In addition to peer-reviewed publications inHIV/AIDS, vaccine-preventable diseases and genetic epidemiology, he has substantial clinical and programmatic experience in the control of tropical and infectious diseases at the global, national, subnational and health facility levels.
Dr. Ogbuanu joined the U.S. Centers for Disease Control and Prevention (CDC) in 2009 as an Epidemic Intelligence Service (EIS)officer with the Global Immunization Division. Over the past 10 years, he has worked for CDC at the Headquarters and as a detailee to the World Health Organization (WHO) in Geneva. During this period, Dr. Ogbuanu has advanced implementation research and policy at the global level through quantitative and qualitative health research, program design and implementation, technical policy development, and international health diplomacy. He has led or participated in multiple global multilateral working groups and sub-teams and has managed successful collaborations and direct technical support in Asia, Africa, Western Pacific, Eastern Mediterranean, Europe and the Americas. Dr. Ogbuanu is adept at managing cross-functional teams and complex relationships with key global development partners, includingUSAID, the Gavi Alliance, the Gates Foundation, US-CDC, vaccine manufacturers, UNICEF, and ministries of health, with a view to reduce preventable childhood mortality and promote equitable use of health interventions. His greatest passion is in applying public health science and strategies to reduce disease morbidity and mortality in low and middle countries (LMICs).
Dr. Ogbuanu is a recipient of multiple awards, including the USC Gerry Sue Arnold Alumni Award (2019); the CDC Excellence in Public Health Service Award, (2014); CDC Award for Excellence in Public Health Protection (2010); USC Doctoral Achievement Award (2009); USC Outstanding Epidemiology Student (2008-2009 session); Michael D. Jarrett Scholarship Award in Recognition of Leadership Potential in Public Health Administration (2005-2006); World Bank Scholar (2004-2006); among others.He completed his medical training at the University of Nigeria in 1998. Following six years of clinical practice in Nigeria, he relocated to the United States to pursue a postgraduate education in Public Health, obtaining his master of public health (MPH) degree in 2006, and his PhD in Epidemiology and Biostatistics in 2009, from the University of South Carolina (USC).
Dr. Amara Jambai currently holds the position of Deputy Chief Medical Officer at the Ministry of Health and Sanitation of Sierra Leone. He is the former Director for Disease Prevention and Control at the same ministry. From 2002 through 2008, Dr. Jambai was the District Medical Officer for the Western area in Sierra Leone. Dr. Jambai’s fields of professional concentration include healthcare delivery in outbreak response, epidemiology, and surveillance of infectious diseases. With regard to infectious diseases, he has conducted research on cholera, yellow fever, and viral hemorrhagic fevers. Dr. Jambai was President of the Sierra Leone Medical and Dental Association from 2009 to 2010 and continues to be a member of the said Association. From 2011 to 2012, Dr. Jambai represented Sierra Leone at WHO’s Regional Committee for Africa.
Key Partners
CHAMPS Working in Sierra Leone to Save Lives
Discover how CHAMPS is saving children’s lives in Sierra Leone. Read more about our transformative, data-driven work and inspiring stories of change.